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Abstract Procalcitonin (PCT) has been shown to be of
additional value in the work-up of a febrile patient. This
study is the first to investigate the additional value of PCT
in an Afro-Caribbean febrile population at the emergency
department (ED) of a general hospital. Febrile patients were
included at the ED. Prospective, blinded PCT measure-
ments were performed in patients with a microbiologically
or serologically confirmed diagnosis or a strongly suspected
diagnosis on clinical grounds. PCT analysis was performed
in 93 patients. PCT levels differentiated well between
confirmed bacterial and confirmed viral infection (area
under the curve [AUC] of 0.82, sensitivity 85%, specificity
69%, cut-off 0.24 ng/mL), between confirmed bacterial
infection and non-infectious fever (AUC of 0.84, sensitivity
90%, specificity 71%, cut-off 0.21 ng/mL) and between all
bacterial infections (confirmed and suspected) and non-
infectious fever (AUC of 0.80, sensitivity 85%, specificity
71%, cut-off 0.21 ng/mL). C-reactive protein (CRP) levels
were shown to be less accurate when comparing the same
groups. This is the first study showing that, in a non-
Caucasian febrile population at the ED, PCT is a more
valuable marker of bacterial infection than CRP. These
results may improve diagnostics and eventually decrease
antibiotic prescriptions in resource-limited settings.
Introduction
Infectious diseases are a major cause of morbidity and
mortality worldwide, particularly in tropical regions [1–3].
Traditionally, fever has been associated with bacterial
infection. However, in up to 50% of febrile people, fever
is caused by non-bacterial infection or other inflamma-
tory conditions, such as malignancy or auto-immune
disease [4, 5]. Because untreated bacterial infections may
result in serious complications, the majority of patients
with fever receive antibiotic treatment, leading to the
overprescription of antibiotics and contributing to the
development of antimicrobial resistance, increasing costs
and possible adverse effects [6].
Neither clinical signs and symptoms, nor current
biomarkers such as C-reactive protein (CRP) have, as a
single marker, sufficient power to discriminate the aetiology
of fever [7–9]. Lately, procalcitonin (PCT) has been added
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DOI 10.1007/s10096-010-1150-5to the diagnostic work-up of febrile patients. Levels of PCT,
a prohormone of calcitonin normally produced by the
thyroid in physiological conditions, rise dramatically during
bacterial infection, whereas low levels are detected during
viral infections or non-infectious febrile conditions [10–13].
Both the diagnostic and prognostic properties of PCT
have been shown to be superior to CRP in numerous
studies [11, 13–16].
PCT is (still) relatively expensive, which limits its
application in resource-poor settings in tropical regions
where infectious diseases are widely prevalent. Since
antibiotic overuse also tends to be a large problem in these
regions, improvement of the diagnostic work-up of fever is
required here in particular. Unfortunately, research on PCT
has almost exclusively focused on Caucasian populations in
Northern countries. As such, it is difficult to apply these
results directly to patients in tropical regions with different
disease spectra and different genetic backgrounds.
Therefore, this study aims to investigate the diagnostic
and prognostic value of PCT and CRP in an Afro-
Caribbean febrile population at the emergency department
(ED) of a general hospital.
Materials and methods
Study design and patients
The study was conducted at the ED of the St. Elisabeth
Hospital, Curaçao, Netherlands Antilles, and was designed
as a single-centre, observational cohort study. The study
was approved by the local ethics committee for human
studies. Written informed consent was obtained from all
patients.
Between March 2008 and September 2009, all patients
with fever (rectal T>38.5°C) were included within 24 h
after admission. Clinical data were registered, routine
laboratory measurements were performed and cultures were
taken. The patient follow-up was 60 days.
Supplementary diagnostics were ordered by the attending
physician. At the St. Elisabeth Hospital, bacterial diagnostics
(i.e. cultures of body fluids and faeces) can be ordered
routinely; viral diagnostics are limited to serology only.
Regular imaging by means of X-ray, computed tomography
(CT) and magnetic resonance imaging (MRI) can be
performed. No nuclear imaging can be performed.
Definitions
Final diagnoses were made at discharge by an independent
physician and again in retrospect by the main investigator,
using all of the available data, including culture results,
serology, radiology and pathology data. In the case of a
discrepancy between discharge diagnosis and the diagnosis
in retrospect, an independent senior internist was asked to
give a final clinical diagnosis.
When a causative bacterium or virus could be identified,
either by culture or viral serology, in concordance with
patient history and clinical signs and symptoms, patients
were assigned to the ‘confirmed bacterial’ or ‘confirmed
viral’ groups. Confirmed parasites and fungi were classified
as ‘confirmed infectious—other’.
When a specific micro-organism could not be identified,
but clinical signs and symptoms were consistent with
radiological or pathology findings—for instance, a clear
history of fever, productive cough and dyspnoea, abnormal
pulmonary auscultation and an infiltrate on the X-thorax—a
clinical diagnosis was assigned and patients were assigned
to the ‘suspected bacterial’ group or the ‘suspected viral’
group. Patients who were discharged without a clear—
infectious or non-infectious—diagnosis were included in
the ‘rest’ group. When a non-infectious cause of fever,
without the presence of pathogenic micro-organisms, could
be identified, patients were confined to the ‘non-infectious’
group.
Measurements
Blood samples were obtained by venapuncture at
inclusion. Samples were centrifuged within 15 min (2×
4,000 rpm at 4°C for 10 min), aliquoted in 1-mL
portions and stored at −70°C. The blood was routinely
analysed for haematological and biochemical variables,
including CRP. Leukocyte count and differential was
performed on the Siemens ADVIA 120 haematology
analyser, using light scatter, differential white blood cell
(WBC) lysis and myeloperoxidase staining to determine
WBC parameters. CRP measurements were performed on
the Abbott c8000 chemistry analyser using a latex-
enhanced immunoturbidimetric method. Prospective,
blinded PCT measurements were performed by using a
time-resolved amplified cryptate emission (TRACE)
technology assay (Kryptor PCT, Brahms, Hennigsdorf,
Germany) in those patients assigned to the ‘confirmed
bacterial’, ‘confirmed viral’, ‘confirmed infectious—other’ ,
‘suspected bacterial’, ‘suspected viral’ and ‘non-infectious’
groups.
All samples were measured in a blinded fashion without
knowledge of the clinical status of the subjects.
Data analysis
Data were analysed using SPSS version 17.0. Data are
presented as numbers with percentages or as medians with
corresponding interquartile ranges (IQRs). Associations
between the presence and absence of bacterial infection
832 Eur J Clin Microbiol Infect Dis (2011) 30:831–836and levels of PCT, CRP and leukocytes were quantified
using logistic regression analysis and are expressed as odds
ratios (ORs) with 95% confidence intervals (CIs) and p-
values. Areas under the curve (AUC) of the receiver
operating characteristic (ROC) curve were calculated. A
p-value<0.05 was considered to be statistically significant.
Results
Patients
During the study period, 462 patients with fever were
identified. In 120 patients (94% Afro-Caribbean), a con-
firmed or strongly suspected diagnosis could be established.
Due to logistical problems—i.e. blood not processed or
stored properly—PCT could not be measured in 27 of these
patients. Analysis was performed in 93 patients. The patient
characteristics are shown in Table 1. Sixty-seven patients
(72.0%) were hospitalised; of these patients, 13 patients
(14.0%) died within the follow-up period of 60 days
(median 9 days after inclusions, IQR 2–31 days) and seven
patients (7.5%) were admitted to the intensive care unit.
The final diagnoses are given in Table 2.I n4 2
patients (45.2%), bacterial infection was confirmed; in 26
patients (28.0%), bacterial infection was suspected. In
four patients (4.3%), viral infection was confirmed; in 14
patients (15.1%), viral infection was suspected. In eight
patients (8.6%), a non-infectious cause of fever was
identified (three malignancy, two drug-induced fever, extra-
uterine gravidity, sickle cell crisis, anaphylaxis).
Markers of infection
The levels of PCT, CRP and leukocytes are shown in
Fig. 1. The median PCT levels were 0.96 ng/mL (IQR
0.19–5.22 ng/mL) in the overall cohort, 1.91 ng/mL (IQR
Table 1 Patient characteristics. Patient cohort of adults (n=93) presenting with fever to the emergency department
All, n=93 n (%)/median (IQR) Bacterial infection,
n=68n (%)/median (IQR)
No bacterial infection,
n=25n (%)/median (IQR)
p-value
Age (years) 56 (36–72) 62 (43.5–73.5) 36 (28–53.8) <0.001
Sex, male 55 (59.1) 40 (58.8) 16 (64.0) NS
Duration of fever before inclusion (days) 0 (0–1) 0 (0–1) 0 (0–1) NS
Clinical signs
Temperature (°C) 39.0 (38.8–39.8) 39.3 (38.9–39.8) 39.0 (38.7–39.5) NS
Tachypnoea 20 (21.5) 16 (25.4) 2 (8.0) <0.01
Tachycardia 57 (61.3) 43 (68.2) 14 (56.0) NS
Mean arterial blood pressure (mmHg) 110 (97–127) 111 (98–127) 107 (97–125) NS
Laboratory values
CRP (mg %) 12.1 (2.6–21.9) 15.3 (6.2–25.3) 2.8 (1.0–6.8) <0.001
Leukocytes (giga/L) 11.4 (6.9–18.3) 13.1 (8.1–19.0) 9.0 (5.0–12.3) NS
PCT (ng/mL) 0.96 (0.21–5.16) 1.91 (0.32–8.73) 0.19 (0.12–0.66) <0.001
Outcome
Mortality 12 (12.9) 11 (17.5) 1 (4.0) <0.001
Hospitalisation 66 (71.0) 49 (77.8) 18 (72.0) NS
Duration of hospital stay (days) 9 (4–15) 7 (1–13) 4 (0–7) 0.01
Table 2 Final diagnosis of patients (n=93) presenting with fever to
the emergency department
Diagnosis n
Urinary tract infection 21
Bacterial pneumonia 20
Dengue fever 9
Skin infection 7
Bacterial sepsis, focus unknown 6
Diabetic foot 3
HIV 3
Bacterial meningitis 2
Central line sepsis 2
Viral gastro-enteritis 2
Pelvic inflammatory disease 2
Abscess 1
Viral pneumonia 1
Viral meningitis 1
Viral respiratory tract infection 1
Diverticulitis 1
Cholangitis 1
Bacterial gastro-enteritis 1
Influenza 1
Non-infectious fever 8
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bacterial infection and 0.22 ng/mL (IQR 0.11–1.52 ng/mL)
in patients with confirmed and suspected viral infection; the
median CRP levels were 12.1 mg % (IQR 2.4–22.0 mg %),
15.3 mg % (IQR 6.0–25.6 mg %) and 2.7 mg % (IQR 1.3–
5.8 mg %); and the median leukocyte levels were 11.4 giga/L
(IQR 6.9–18.6 giga/L), 13.1 giga/L (IQR 8.0–19.7 giga/L)
and 6.6 giga/L (IQR 4.8 – 10.0 giga/L) in the same groups,
respectively.
Diagnostic properties
PCT levels differentiated well between infectious and non-
infectious fever (AUC of 0.76, sensitivity 78%, specificity
71%, cut-off 0.21 ng/mL; Fig. 2), between confirmed
bacterial and confirmed viral infection (AUC of 0.82,
sensitivity 85%, specificity 69%, cut-off 0.24 ng/mL),
between confirmed bacterial infection and non-infectious
fever (AUC of 0.84, sensitivity 90%, specificity 71%, cut-
off 0.21 ng/mL) and between all bacterial infections
(confirmed and suspected) and non-infectious fever (AUC
of 0.80, sensitivity 85%, specificity 71%, cut-off
0.21 ng/mL; Fig. 3). CRP levels were shown to be less
accurate when comparing the same groups (AUC of 0.69,
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Fig. 1 Levels of C-reactive protein (CRP), procalcitonin (PCT) and
leukocytesinpatientspresentingwithfevertotheemergencydepartment.
PanelAshowsthelevelsofallpatientstogether,panelBshowsthelevels
in patients with (confirmed or suspected) bacterial infection, panel C
shows the levels in patients with non-bacterial fever and panel D shows
the levels in patients with (confirmed or suspected) viral infection
Fig. 2 Receiver operating characteristic (ROC) curve showing the
diagnostic value of CRP, leukocytes and PCT for the differentiation
between infectious fever and non-infectious fever. Area under the
curve (AUC) for PCT 0.76 (sensitivity 78%/specificity 71% at cut-off
0.21 ng/mL); CRP 0.59 (88%/43% at 0.85 mg %); leukocytes 0.41
(10%/100% at 28.0 giga/L), respectively
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of 0.65, sensitivity 89%, specificity 43%, cut-off 8.5 mg
%; AUC of 0.64, sensitivity 90%, specificity 43%, cut-off
8.5 mg %, respectively).
Prognostic properties
A significant correlation between PCT levels and confirmed
bacterial infection was observed (OR 1.088; 95% CI 1.018–
1.162; p=0.013). A less strong but still significant
correlation between CRP levels and confirmed bacterial
infection could be found (OR 1.046; 95% CI 1.004–1.090;
p=0.03). Leukocyte levels did not correlate with bacterial
infection (OR 1.043; 95% CI 0.986–1.104; p=0.14).
Discussion
In this study, we investigated the diagnostic and prognostic
value of PCT and CRP in the diagnostic work-up of febrile
patients at the ED of a general Caribbean hospital. Levels
of PCT showed better diagnostic and prognostic properties
than CRP. This is the first study to show that, in a non-
Caucasian febrile population at the ED, PCT is a more
valuable marker of bacterial infection than CRP.
It has recently been shown in many studies that inter- and
intra-racial genetic polymorphisms of inflammatory genes,
including polymorphisms in the CRP complex, are wide-
spread and strongly influence the inflammatory response and
t h es u s c e p t i b i l i t yt oi n f e c t i o u sd i s e a s e s[ 17, 18]. Our study
suggests that, regardless of multiple differences between
genetic backgrounds and the different disease spectra, the
positive results of PCT studies in Northern, Caucasian
populations can likely be applied to an Afro-Caribbean
population in a tropical region.
The relatively high costs of PCT measurements discour-
age the application of PCT in resource-poor settings.
Furthermore, the PCT test is not readily available on most
routine clinical chemistry analysers. However, an improved
diagnostic work-up of fever is likely to result in a decreased
use of antibiotics, which will not only limit the costs of the
drugs themselves, but also side-effect-related costs. In the
long term, increased costs due to antibiotic resistance are
avoided. Indeed, studies have shown that the use of a PCT-
based algorithm reduced the use of antibiotics in a general
practice setting [11]. Moreover, recent studies have
demonstrated that single PCT measurements may also be
used to safely guide the duration of antibiotic therapy. In
the landmark ProHOSP trial, a large trial investigating
1,359 patients with lower respiratory tract infections, a
PCT-based algorithm significantly reduced the duration of
antibiotic therapy, as well as frequencies of antibiotic side-
effects and duration of stay in the hospital [13]. Although
no cost-effectiveness analysis was carried out, costs were
obviously reduced this way.
Some limitations concerning this study have to be noted.
First, the study was an observational study, thus, providing
weaker empirical evidence than a randomised controlled
study would provide. Also, in many febrile patients, no
definite diagnosis could be established and PCT was not
measured. This may have caused some selection bias; it
could be suggested that patients with a clear diagnosis were
more severely ill, resulting in more aggressive diagnostic
procedures. This may explain the very high AUCs in this
study, assuming that, in more severely ill subjects, the acute
phase reaction is activated more significantly in case of a
bacterial infection. Nevertheless, the primary aim of our
study was to compare PCT and CRP within the same study
subjects. In addition, diagnostic possibilities in Curaçao are
relatively limited. Viral diagnostics generally only consist
of serology with emphasis on Dengue fever; polymerase
chain reaction (PCR) is not used routinely. Therefore, our
study may underestimate the presence of viral disease,
which may have influenced overall outcomes.
In conclusion, PCT is a valuable marker of bacterial
infection in Afro-Caribbean febrile patients at the ED, with
greater predictive value than CRP and other markers of
infection. By implementing PCT as a routine marker in the
work-up of febrile patients, the diagnostic power will be
improved. This may eventually lead to a reduction in
antibiotic prescriptions, costs and adverse events.
Fig. 3 ROC curve showing the diagnostic value of CRP, leukocytes
and PCT for the differentiation between confirmed bacterial infection
and non-infectious fever. AUC PCT 0.84 (sensitivity 90%/specificity
71% at cut-off 0.21 ng/mL); CRP 0.65 (89%/43% at 0.85 mg %);
leukocytes 0.48 (18%/100% at 28.0 giga/L), respectively
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